Webster Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Webster Bank’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-120	Closed	-$22K	–	560
2021 Q2	$22K	Hold	120	–	–	﹤0.01%	398
2021 Q1	$18K	Hold	120	–	–	﹤0.01%	432
2020 Q4	$19K	Hold	120	–	–	﹤0.01%	410
2020 Q3	$14K	Hold	120	–	–	﹤0.01%	406
2020 Q2	$13K	Hold	120	–	–	﹤0.01%	402
2020 Q1	$11K	Sell	120 -5,000	-98%	-$491K	﹤0.01%	403
2019 Q4	$554K	Buy	5,120 +5,000	+4,167%	+$535K	0.07%	143
2019 Q3	$12K	Hold	120	–	–	﹤0.01%	430
2019 Q2	$16K	Hold	120	–	–	﹤0.01%	409
2019 Q1	$16K	Hold	120	–	–	﹤0.01%	405
2018 Q4	$12K	Hold	120	–	–	﹤0.01%	407
2018 Q3	$17K	Sell	120 -6,880	-98%	-$863K	﹤0.01%	419
2018 Q2	$869K	Hold	7,000	–	–	0.13%	123
2018 Q1	$780K	Sell	7,000 -3,000	-30%	-$359K	0.11%	129
2017 Q4	$1.2M	Hold	10,000	–	–	0.16%	120
2017 Q3	$1.4M	Hold	10,000	–	–	0.2%	108
2017 Q2	$1.22M	Buy	10,000 +2,000	+25%	+$233K	0.18%	113
2017 Q1	$970K	Hold	8,000	–	–	0.15%	125
2016 Q4	$979K	Buy	8,000 +1,000	+14%	+$122K	0.14%	121
2016 Q3	$858K	Hold	7,000	–	–	0.12%	130
2016 Q2	$817K	Buy	7,000 +2,000	+40%	+$284K	0.12%	126
2016 Q1	$696K	Buy	5,000 +3,000	+150%	+$440K	0.11%	133
2015 Q4	$382K	Hold	2,000	–	–	0.06%	154
2015 Q3	$313K	Hold	2,000	–	–	0.06%	157
2015 Q2	$362K	Buy	+2,000	New	+$345K	0.06%	153

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Webster Bank's ALXN Position: Q3 2021 in Review

Webster Bank sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 120 shares — an estimated $22K sold.

Webster Bank first reported a position in ALXN in Q2 2015 and held it in 25 quarters. The position peaked at $1.4M in Q3 2017. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Webster Bank reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Webster Bank sold 120 Alexion Pharmaceuticals shares in Q3 2021, an estimated $22K.
Webster Bank first reported a position in Alexion Pharmaceuticals in Q2 2015 and held it in 25 quarters.
Webster Bank's Alexion Pharmaceuticals position peaked at $1.4M in Q3 2017.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Webster Bank's 13F filing for Q3 2021, filed 12 Oct 2021.